RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
Portfolio Pulse from
DeepHealth, a subsidiary of RadNet, has received expanded FDA clearance for its SmartMammo Dx software, now compatible with GE HealthCare's mammography systems. This expansion aims to enhance breast cancer screening programs.
November 29, 2024 | 11:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RadNet's subsidiary, DeepHealth, has expanded FDA clearance for its SmartMammo Dx software, now compatible with GE HealthCare's mammography systems. This could enhance RadNet's market position in AI-powered health informatics.
The expanded FDA clearance for SmartMammo Dx increases its compatibility with more mammography systems, potentially boosting RadNet's market reach and revenue in the AI health informatics sector. This development is likely to positively impact RadNet's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90